clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Genetic Variant Identified Responsible for Higher Risk of ALL in Latinos
News & Features
Cancer Drug Part of New Combination Therapy Targeting TB
News & Features
New Atlas of Rare Stem and Progenitor Cells Reveals New Cell…
News & Features
Extensive Lymph Node Removal Can Be Avoided If Breast Cancer Responds…
News & Features
NGS Picks up Tumor Microsatellite Instability Better than IHC
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Authors
Posts by Gary M. Oosta, Ph.D.
Gary M. Oosta, Ph.D.
3 POSTS
0 COMMENTS
Ph.D.
Molecular Dx
Eye on Point-of-Care Diagnostics
September 4, 2014
Molecular Dx
POC Diagnostics in the Cardiovascular Disease Space
August 5, 2014
Molecular Dx
NGS and Cancer Biomarker Market Metrics
June 10, 2014
Related Content
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
AbbVie Pumps up Autoimmune Portfolio by Acquiring Landos
Colorectal Cancer Gene MUTYH Linked to Other Solid Tumors
Precision Immune Start-Up Mirador Launches with $400M+
Inside Precision Medicine